Mesirow Financial Investment Management, Inc.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-08
Total Holdings
593
Total Value
5160168880
Accession Number
0001085146-25-002744
Form Type
13F-HR
Manager Name
Mesirow Financial Investment Management, Inc.
Data Enrichment
84% identified
496 identified97 unidentified

Holdings

593 positions
Manager:
Search and click to pin securities to the top
Page 30 of 30
Douglas Elliman Inc.
Shares:
18500(+0.0%)
Value:
$31.8M(+3.0%)
Esperion Therapeutics, Inc.
Shares:
20000(+0.0%)
Value:
$28.8M(-34.5%)
KORU Medical Systems, Inc.
Shares:
10959(+0.0%)
Value:
$27.8M(-34.0%)
ThredUp Inc.
Shares:
10693(+0.0%)
Value:
$25.8M(+73.4%)
NEPHROS INC
Shares:
13800(+0.0%)
Value:
$23.7M(+17.0%)
NEW PACIFIC METALS CORP
Shares:
20000
Value:
$22.1M
LIQTECH INTERNATIONAL INC
Shares:
13754(+0.0%)
Value:
$20.5M(-19.1%)
Lineage Cell Therapeutics, Inc.
Shares:
20000(+0.0%)
Value:
$9.0M(-10.1%)
Vaxart, Inc.
Shares:
20000(+0.0%)
Value:
$8.1M(-38.5%)
SANGAMO THERAPEUTICS, INC
Shares:
11800(+0.0%)
Value:
$7.7M(-35.7%)
N94209108
Shares:
10000(+0.0%)
Value:
$3.3M(-34.5%)
P3 Health Partners Inc.
Shares:
15000(+0.0%)
Value:
$2.5M(-27.0%)
N94209116
Shares:
15000
Value:
$332.0K